Color Genomics | Burlingame, CA | Full Stack, Backend, Bioinformatics
Color Genomics is democratizing access to high-quality genetic testing. Our first product, a breast and ovarian cancer risk test that's 1/10 the price of existing offerings, launched in April and was covered in Fast Company, Forbes, and the New York Times[1].
We're lucky to have a team that represents the best from of the worlds of software development and next-generation DNA sequencing, and a scientific advisory board that includes the scientist who discovered the BRCA1 gene.
If you're an engineer who's willing to learn about biological problems, or have experience in next-generation sequencing, feel free to contact me directly: nish@getcolor.com
Color Genomics | Burlingame, CA | Onsite, Full-time | {UI/Frontend, Backend, Full-stack} Engineering, Bioinformatics
Color Genomics is democratizing access to high-quality genetic testing. Our first product, a breast and ovarian cancer risk test that's 1/10 the price of existing offerings, launched 2 weeks ago and was covered in Fast Company, Forbes, and the New York Times[1]. We're lucky to have a team that represents the best from of the worlds of software development and next-generation DNA testing, and a scientific advisory board that includes the scientist who discovered the BRCA1 gene. If you're an engineer who's willing to learn about biological problems, or have experience in next-generation sequencing, feel free to contact me directly: nish@getcolor.com
Color Genomics | Burlingame, CA | Onsite, Full-time | Full Stack, Backend, Bioinformatics
Color Genomics is democratizing access to high-quality genetic testing. Our first product, a breast and ovarian cancer risk test that's 1/10 the price of existing offerings, launched 2 weeks ago and was covered in Fast Company, Forbes, and the New York Times[1].
We're lucky to have a team that represents the best from of the worlds of software development and next-generation DNA testing, and a scientific advisory board that includes the scientist who discovered the BRCA1 gene.
If you're an engineer who's willing to learn about biological problems, or have experience in next-generation sequencing, feel free to contact me directly: nish@getcolor.com
We started by assuming most of what we saw on paper lack credibility. We questioned their abilities, in a friendly way, and made sure they proved to us what they claimed. We also cast a wide net - we didn't just assume because we liked someone at first that we should just wrap things up. That candidate was the best of maybe 3-4 people we brought in for in-person interviews. Instead of 1 intern candidate whom we felt we knew.
